SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950134-05-023686
Filing Date
2005-12-22
Accepted
2005-12-22 11:49:12
Documents
3
Period of Report
2005-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K d31460e8vkza.htm 8-K/A 13161
2 DEVELOPMENT AND LICENSE AGREEMENT d31460exv10w2.htm EX-10.2 255329
3 GRAPHIC d31460d3146001.gif GRAPHIC 1427
  Complete submission text file 0000950134-05-023686.txt   272137
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1220
Type: 8-K/A | Act: 34 | File No.: 000-23186 | Film No.: 051280798
SIC: 2836 Biological Products, (No Diagnostic Substances)